AI주식인사이트AI Stock Insight
C

이노진

344860KOSDAQ

41.0 / 100

Reference Date: 2026-10-23

Financial Score13.5 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Declined 8.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Inozen is a cosmeceutical company specializing in hair loss and problematic skin care, offering comprehensive solutions including home care, scalp devices, health supplements, and pharmaceuticals both domestically and internationally. In 2024, hair loss products accounted for 82% of sales, utilizing IIT (Initial Intensive Therapy) and DEDS (Different Etiology, Different Solution) systems for personalized treatment. Its skincare product line features mild, acidic pH formulations with soothing effects, under brands like Dr. Medition and Rescuvai.

Number of Employees

58people

Average Salary

40.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
56.15Industry Average 15.000.0Point

3.7x industry avg (risky)

PBR
1.56Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE
1.88Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
0.13Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼9.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼73.9% (2-year basis)

ROE Trend
2.0 / 4

Avg ROE 6.6% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (24%)

Current 1,460Won52-week high 2,25552-week low 1,206
1-month return1.0Point

1m -8.69% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0